Effects of Walking Apnea At High Lung Volume on Hypoalgesia
Condition(s) studied
Investigational drug(s) / intervention(s)
Walking apnea at High Lung Volume: Walking apnea at High Lung Volume Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the experimental group will perform intermittent apneas at high lung volume with a density of 5 seconds, followed by a normal breath of 5 seconds until completing the 6 minutes)
Walking normal breathing: Participants walk at 6 km/h (10% slope) on treadmill for 6 minutes. Participants in the control group will remain breathing normally for these 6 minutes.
Study summary
The aim of this randomized controlled study is to explore the hypoalgesic response of a 6 minutes of intermittent walking apneas training session at high lung volume in healthy subjects; also, as secondary objectives, to analyze the cardiovascular and respiratory response produced during the intervention.
Eligibility
Primary outcome measure(s)
- Pain pressure threshold (PPT) on thumb, anterior tibial and spinous process of C7 — before and after intervention (up 30 minutes)
PPT is tested on the dorsal base of the distal phalanx of the thumb on the dominant side and on the muscle belly of the tibialis anterior on the dominant side. The region to be pressed is marked with a pen. The patient is instructed to report with the first appearance of the sensation of "discomfort". An ascending ramp of 0.5 kg/cm/s is applied, at the rhythm of a metronome. The measurement is started on the thumb, and alternated with tibia and C7 until 3 measurements of each region are obtained, enough time to give 30 seconds of rest between measurements in the same region. This protocol has demonstrated high inter observer reliability measuring healthy subjects (ICC = 0.91).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CSEU LaSalle | Madrid | Spain | Recruiting |
More Universidad Rey Juan Carlos trials in Spain
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06638528 on ClinicalTrials.gov ↗ ← All trials in Spain